Skip to main content

Table 1 Coagulation parameters.

From: Coagulation Disorders in Subjects Undergoing Pump-Driven Veno-Venous Ecco2-R For Severe Acute Hypercapnic Respiratory Failure - a Single Center Experience

  baseline* -72h -48h -24h day of bleeding
hemoglobin (G/l) 114.5 ( ± 24.3) 97.8 ( ± 11.8) 88.8 ( ± 16.9) 79 ( ± 14.5) 81.8 ( ± 14.1)
thrombocytes (G/l) 195.5 ( ± 125.5) 193.3 ( ± 136.0) 171 ( ± 122.5) 141.8 ( ± 122.1) 125.5 ( ± 100.2)
fibrinogen (mg/dl) 370 ( ± 97.4) 358.8 ( ± 133.9) 343.5 ( ± 136.3) 255.5 ( ± 136.2) 235.5 ( ± 142.9)
AT III (%) 101 ( ± 20.9) 86 ( ± 25.7) 80.5 ( ± 21.6) 69.5 ( ± 23.7) 74 ( ± 14.5)
D-DIMER (µg/l) 1170 ( ± 435.4) 5079 ( ± 6597) 7569 ( ± 11340) 11048 ( ± 16140) 12709 ( ± 15453)
PT (%) 90.8 ( ± 18.7) 91 ( ± 19.8) 86.8 ( ± 18.8) 81.8 ( ± 16.9) 82.5 ( ± 24.8)
aPTT (sec) 38.8 ( ± 12.0) 39.8 ( ± 10.4) 46.8 ( ± 11.3) 49.5 ( ± 15.1) 36.8 ( ± 7.7)
Heparin (IU/kg/day) 0 207.8 ( ± 80.5) 259.7 ( ± 84.3) 150.1 ( ± 115.7) 78.33 ( ± 97.1)
  1. Results are presented as mean ( ± SD).
  2. *baseline refers to the last value before application of ECCO2-R